← Leaderboards
Alice S Chen-Plotkin
University Of Pennsylvania
$18,977,934
Attributed
$20,340,022
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.6M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,892,170 · 14
By mechanism
P01$8,750,754 · 3
R01$8,265,086 · 2
U01$2,573,216 · 2
U19$2,507,784 · 1
T32$2,158,609 · 2
P30$1,515,388 · 2
Top collaborators
- Edward Byung-Ha Lee3 shared
- Virginia M Lee3 shared
- Frances E Jensen1 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- John Q. Trojanowski$38,320,321
- Virginia M Lee$38,958,370
- Vivianna M Van Deerlin$6,259,100
- Kelvin C Luk$5,179,849
- Barbara Elizabeth Spencer$218,266
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposReportingDementiaSamplingProteinsParkinson DiseaseBiological MarkersInvestigationGeneticBiochemicalMolecularProgramsS Disease Related DementiaCohortS DiseaseAffectPlasmaCognitiveAlpha SynucleinImpaired CognitionCharacteristicsBiologicalPathologyCells
Grant awards (52)
Mechanisms Underlying Heterogeneity of Cognitive Outcomes in Synucleinopathy$3,699,973
P01 · FY2025 · AG · contact PI
Understanding biomarkers of cognitive decline in Lewy body diseases$718,338
R37 · FY2025 · NS · contact PI
Training in age related neurodegenerative diseases$576,454
T32 · FY2025 · AG · contact PI
Project III: Heterogeneity of Outcomes in Synucleinopathies: Insights from Genomics and Proteomics$441,906
P01 · FY2025 · AG · contact PI
Biomarker Core$245,677
P30 · FY2025 · AG · contact PI
Core A: Administrative Core$121,387
P01 · FY2025 · AG · contact PI
Understanding biomarkers of cognitive decline in Lewy body diseases$39,250
R37 · FY2025 · NS · contact PI
Mechanisms Underlying Heterogeneity of Cognitive Outcomes in Synucleinopathy$3,852,175
P01 · FY2024 · AG · contact PI
Understanding biomarkers of cognitive decline in Lewy body diseases$723,980
R37 · FY2024 · NS · contact PI
TMEM106B in neurodegenerative disease$597,864
R01 · FY2024 · NS · contact PI
Training in age related neurodegenerative diseases$578,228
T32 · FY2024 · AG · contact PI
Project III: Heterogeneity of Outcomes in Synucleinopathies: Insights from Genomics and Proteomics$510,328
P01 · FY2024 · AG · contact PI
Biomarker Core$245,677
P30 · FY2024 · AG · contact PI
Core A: Administrative Core$124,985
P01 · FY2024 · AG · contact PI
Biomarkers of cognitive decline in Parkinson's Disease$720,145
R01 · FY2023 · NS · contact PI
TMEM106B in neurodegenerative disease$597,864
R01 · FY2023 · NS · contact PI
Training in age related neurodegenerative diseases$542,019
T32 · FY2023 · AG
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"$480,911
U19 · FY2023 · AG · contact PI
Biomarker Core$245,677
P30 · FY2023 · AG · contact PI
Biomarkers of cognitive decline in Parkinson's Disease$716,147
R01 · FY2022 · NS · contact PI
TMEM106B in neurodegenerative disease$597,864
R01 · FY2022 · NS · contact PI
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"$566,343
U19 · FY2022 · AG · contact PI
Biomarker Core$244,865
P30 · FY2022 · AG · contact PI
Biomarkers of cognitive decline in Parkinson's Disease$712,267
R01 · FY2021 · NS · contact PI
TMEM106B in neurodegenerative disease$597,250
R01 · FY2021 · NS · contact PI
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"$452,681
U19 · FY2021 · AG · contact PI
Biomarker Core$264,780
P30 · FY2021 · AG · contact PI
Biomarkers of cognitive decline in Parkinson's Disease$706,318
R01 · FY2020 · NS · contact PI
TMEM106B in neurodegenerative disease$596,024
R01 · FY2020 · NS · contact PI
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"$518,460
U19 · FY2020 · AG · contact PI
Remapping Clinical Neuroscience through Translation and Innovation Training (ReCoNnecT-IT)$461,908
T32 · FY2020 · NS
Biomarkers of cognitive decline in Parkinson's Disease$722,761
R01 · FY2019 · NS · contact PI
Project IV "Tackling Heterogeneity of Cognitive Trajectory in LBD"$489,389
U19 · FY2019 · AG · contact PI
Towards a blood-based diagnostic panel for confirmation of Parkinson's disease$156,645
U01 · FY2019 · NS · contact PI
Towards a blood-based diagnostic panel for confirmation of Parkinson's disease$156,645
U01 · FY2018 · NS · contact PI
Towards a blood-based diagnostic panel for confirmation of Parkinson's disease$471,390
U01 · FY2017 · NS · contact PI
The Genetic Regulation and Disease Function of the Frontotemporal Dementia Protei$340,798
R01 · FY2017 · NS · contact PI
UPenn ADCC Biomarker Core$268,712
P30 · FY2017 · AG · contact PI
The Genetic Regulation and Disease Function of the Frontotemporal Dementia Protei$340,798
R01 · FY2016 · NS · contact PI
Unbiased Approaches to Novel Biomarker Discovery in Parkinson's Disease$331,894
U01 · FY2016 · NS · contact PI
The Genetic Regulation and Disease Function of the Frontotemporal Dementia Protei$340,798
R01 · FY2015 · NS · contact PI
Unbiased Approaches to Novel Biomarker Discovery in Parkinson's Disease$331,894
U01 · FY2015 · NS · contact PI
The Genetic Regulation and Disease Function of the Frontotemporal Dementia Protei$337,390
R01 · FY2014 · NS · contact PI
Unbiased Approaches to Novel Biomarker Discovery in Parkinson's Disease$328,576
U01 · FY2014 · NS · contact PI
The Genetic Regulation and Disease Function of the Frontotemporal Dementia Protei$340,798
R01 · FY2013 · NS · contact PI
Unbiased Approaches to Novel Biomarker Discovery in Parkinson's Disease$320,278
U01 · FY2013 · NS · contact PI
Unbiased Approaches to Novel Biomarker Discovery in Parkinson's Disease$475,894
U01 · FY2012 · NS · contact PI
Regulation of gene expression in frontotemporal dementia: A genome-wide approach$127,953
K08 · FY2012 · AG · contact PI
Regulation of gene expression in frontotemporal dementia: A genome-wide approach$127,953
K08 · FY2011 · AG · contact PI
Regulation of gene expression in frontotemporal dementia: A genome-wide approach$127,953
K08 · FY2010 · AG · contact PI
Regulation of gene expression in frontotemporal dementia: A genome-wide approach$127,953
K08 · FY2009 · AG · contact PI
Regulation of gene expression in frontotemporal dementia: A genome-wide approach$127,953
K08 · FY2008 · AG · contact PI